Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Hitherto unseen survival in an ALK-positive-patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Fatal outcome of malignant transformation of hidradenitis suppurativa: A case report and literature review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. CENTRAL PRECOCIOUS PUBERTY IN TWO BOYS WITH PRADER-WILLI SYNDROME ON GROWTH HORMONE TREATMENT

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. A rare case of pseudotumor cerebri in adult Lyme disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Survival of stage 4 ganglioneuroblastoma (GNB) patients is poor; no reports exist of patients surviving up to 5 years (1, 2). We report the clinical and therapeutic course of a patient with stage 4 GNB surviving beyond expectations due to a multimodal treatment approach incorporating new technologies in cancer diagnostic and treatment.

OriginalsprogEngelsk
TidsskriftAACE clinical case reports
Vol/bind5
Udgave nummer12
Sider (fra-til)2085-2087
Antal sider3
ISSN2376-0605
DOI
StatusUdgivet - dec. 2017

ID: 52153496